Astrazeneca AB v. Mylan Laboratories, Inc.
263 F. App'x 861
CourtCourt of Appeals for the Federal Circuit
DecidedJanuary 22, 2008
DocketNos. 2007-1476, 2007-1477, 2007-1478
StatusPublished
This text of 263 F. App'x 861 (Astrazeneca AB v. Mylan Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Astrazeneca AB v. Mylan Laboratories, Inc., 263 F. App'x 861 (Fed. Cir. 2008).
Opinion
ORDER
Order Vacated, See 2008 WL 648541.
The appellant having failed to file an appendix required by Federal Circuit Rule 30(a) within the time permitted by the rules, it is
ORDERED that the notice of appeal be, and the same hereby is, DISMISSED, for failure to prosecute in accordance with the rules.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
263 F. App'x 861, Counsel Stack Legal Research, https://law.counselstack.com/opinion/astrazeneca-ab-v-mylan-laboratories-inc-cafc-2008.